Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM
· Real-Time Price · USD
18.54
-0.22 (-1.17%)
At close: Sep 04, 2025, 3:59 PM
18.45
-0.49%
After-hours: Sep 04, 2025, 07:59 PM EDT
Beam Therapeutics Revenue
Beam Therapeutics reported an annual revenue of $63.52M, reflecting a -83.18% growth. For the quarter ending June 30, 2025, Beam Therapeutics generated $8.47M in revenue.
Revenue (ttm)
63.52M
Revenue Growth
-83.18%
Price / Sales Ratio
32.14
Revenue / Employee
161.62K
Employees
393
Market Cap
1.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 63.52M | -83.18% |
| Dec 31, 2023 | 377.71M | +520.01% |
| Dec 31, 2022 | 60.92M | +17.51% |
| Dec 31, 2021 | 51.84M | +215916.67% |
| Dec 31, 2020 | 24K | +33.33% |
| Dec 31, 2019 | 18K | +Infinity% |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |